Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment...

Published on 15 Mar 2024 on Benzinga

Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment...

Gilead Sciences Inc’s GILD executive revealed the company’s plans to increase its production of cell therapy cancer treatments fourfold by 2026.

In an interview with Reuters, Cindy Perettie, the executive vice president of Gilead’s Kite cell therapy unit, said the advancements stem from significant enhancements in Gilead’s manufacturing processes.

Read the rest of the article

NASDAQ.GILD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75?

GILD stock was trading at around $62 in early June 2022, just before the Fed started increasing...

Forbes 9 May 2024

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight

Comprehensive SWOT analysis highlighting Gilead Sciences Inc's strategic positioning in the bioph...

GuruFocus.com via Yahoo Finance 9 May 2024

Forbes Has Listed Gilead as One of America’s Best

Forbes has listed Gilead as one of America’s Best Employers for Diversity. Gilead Sciences, Inc. ...

3BL CSRwire 6 May 2024

Dominique Jackson Will Host Elizabeth Taylor AIDS Foundation's New York Dinner

The Elizabeth Taylor AIDS Foundation (ETAF) announced today that model, actress, and author...

Broadway World 3 May 2024

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

For Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured...

Zacks via Yahoo Finance 3 May 2024

Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales By Investing.com

The company's HIV product sales saw a 4% rise, while oncology product sales surged by 18%, primar...

Investing.com 29 Apr 2024

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefo...

Zacks via Yahoo Finance 29 Apr 2024

Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat

Gilead Sciences, Inc. GILD reported better-than-expected results in the first quarter, as its los...

Zacks via Yahoo Finance 26 Apr 2024

Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...

Total Revenue: Reached $6.7 billion in Q1 2024, a 5% increase year-over-year, exceeding estimates...

GuruFocus.com via Yahoo Finance 25 Apr 2024

Gilead stock gains on revenue beat, despite a quarterly loss By Investing.com

Gilead Sciences, Inc. (NASDAQ:GILD) has reported a revenue increase in its first quarter of 2024,...

Investing.com 25 Apr 2024

News

Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment...

NASDAQ.GILD price evolution

Want to become a better investor?